(Q39676973)

English

Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells

scientific article published on 22 July 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Fei-fei Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Min Yan

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gui-fang Guo

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Fang Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hui-juan Qiu

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Fei-meng Zheng

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yan Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Qiang Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Xiao-feng Zhu

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Liang-ping Xia

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

22 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1302-1307

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The global breast cancer burden: variations in epidemiology and survival.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Triple-negative breast cancer: risk factors to potential targets

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

The structure and function of initiation factors in eukaryotic protein synthesis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

eIF-4E expression and its role in malignancies and metastases.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Eukaryotic Translation Initiation Factor 4E Regulates Expression of Cyclin D1 at Transcriptional and Post-transcriptional Levels

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Targeting the eukaryotic translation initiation factor 4E for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Exploiting the PI3K/AKT pathway for cancer drug discovery

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Pharmacotherapy of triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9630-0

21 January 2018

Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mRNA cap-binding protein eIF4E in post-transcriptional gene expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching to aromatase inhibitors in early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High eIF4E, VEGF, and microvessel density in stage I to III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-010-9630-0

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39676973&oldid=2203079773"